Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Post-Market Monitoring Can Fill Innovative Switch Data Gaps – Consultants

This article was originally published in The Tan Sheet

Executive Summary

Allowing for post-market monitoring would incentivize sponsors to consider switches and generate data that could inform a decision about potential conditions for safe use “without applying potentially burdensome – and possibly unnecessary – conditions upfront,” Pinney Associates health care consultancy says.

Advertisement

Related Content

FDA Sketches NSURE Novel Switch Initiative In 2012
FDA Sketches NSURE Novel Switch Initiative In 2012
European OTC Switch Still Muted By Regulatory Resistance
European OTC Switch Still Muted By Regulatory Resistance
European OTC Switch Still Muted By Regulatory Resistance
European OTC Switch Still Muted By Regulatory Resistance
Pharmacy Interests Back BTC Models For Third Class
Pharmacy Interests Back BTC Models For Third Class
Pharmacy Interests Back BTC Models For Third Class
FDA Expects OTC Switch Self-Selection Studies To Probe Consumer Thinking

Topics

Advertisement
UsernamePublicRestriction

Register

PS105794

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel